Cancelas, J. A., Gottschall, J. L., Rugg, N., Graminske, S., Schott, M. A., North, A., . . . Corash, L. (2017). Red blood cell concentrates treated with the amustaline (S‐303) pathogen reduction system and stored for 35 days retain post‐transfusion viability: Results of a two‐centre study. Vox sanguinis, 112(3), 210-218. https://doi.org/10.1111/vox.12500
Chicago Style (17th ed.) CitationCancelas, J. A., et al. "Red Blood Cell Concentrates Treated with the Amustaline (S‐303) Pathogen Reduction System and Stored for 35 Days Retain Post‐transfusion Viability: Results of a Two‐centre Study." Vox Sanguinis 112, no. 3 (2017): 210-218. https://doi.org/10.1111/vox.12500.
MLA (9th ed.) CitationCancelas, J. A., et al. "Red Blood Cell Concentrates Treated with the Amustaline (S‐303) Pathogen Reduction System and Stored for 35 Days Retain Post‐transfusion Viability: Results of a Two‐centre Study." Vox Sanguinis, vol. 112, no. 3, 2017, pp. 210-218, https://doi.org/10.1111/vox.12500.